Bartlett & CO. Wealth Management LLC Has $103.45 Million Stock Position in UnitedHealth Group Incorporated (NYSE:UNH)

Bartlett & CO. Wealth Management LLC reduced its position in UnitedHealth Group Incorporated (NYSE:UNH) by 0.3% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 176,942 shares of the healthcare conglomerate’s stock after selling 492 shares during the quarter. UnitedHealth Group comprises about 1.5% of Bartlett & CO. Wealth Management LLC’s portfolio, making the stock its 19th largest position. Bartlett & CO. Wealth Management LLC’s holdings in UnitedHealth Group were worth $103,454,000 at the end of the most recent reporting period.

Other large investors have also made changes to their positions in the company. Kathleen S. Wright Associates Inc. acquired a new stake in UnitedHealth Group in the third quarter valued at about $27,000. Macroview Investment Management LLC grew its holdings in shares of UnitedHealth Group by 671.4% during the 2nd quarter. Macroview Investment Management LLC now owns 54 shares of the healthcare conglomerate’s stock valued at $28,000 after purchasing an additional 47 shares during the last quarter. Delos Wealth Advisors LLC boosted its position in UnitedHealth Group by 757.1% in the first quarter. Delos Wealth Advisors LLC now owns 60 shares of the healthcare conglomerate’s stock valued at $30,000 after buying an additional 53 shares in the last quarter. Bbjs Financial Advisors LLC bought a new position in shares of UnitedHealth Group in the 2nd quarter valued at $31,000. Finally, Global Wealth Strategies & Associates grew its position in UnitedHealth Group by 152.4% during the 3rd quarter. Global Wealth Strategies & Associates now owns 53 shares of the healthcare conglomerate’s stock worth $31,000 after acquiring an additional 32 shares during the last quarter. Institutional investors and hedge funds own 87.86% of the company’s stock.

Analyst Ratings Changes

Several equities analysts have issued reports on the stock. Royal Bank of Canada decreased their price target on shares of UnitedHealth Group from $615.00 to $595.00 and set an “outperform” rating for the company in a research report on Wednesday. TD Cowen upped their target price on UnitedHealth Group from $601.00 to $609.00 and gave the company a “buy” rating in a report on Friday. Argus increased their price objective on shares of UnitedHealth Group from $570.00 to $600.00 and gave the stock a “buy” rating in a research report on Wednesday, July 17th. Hsbc Global Res lowered UnitedHealth Group from a “strong-buy” rating to a “hold” rating in a research report on Thursday. Finally, Truist Financial restated a “buy” rating and issued a $625.00 target price (down from $640.00) on shares of UnitedHealth Group in a research note on Wednesday. Three equities research analysts have rated the stock with a hold rating, eighteen have given a buy rating and two have issued a strong buy rating to the company’s stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $615.58.

UnitedHealth Group Trading Up 0.6 %

NYSE:UNH opened at $569.61 on Friday. The stock has a market capitalization of $525.99 billion, a PE ratio of 37.77, a price-to-earnings-growth ratio of 1.69 and a beta of 0.58. The company has a current ratio of 0.88, a quick ratio of 0.88 and a debt-to-equity ratio of 0.67. The firm’s 50 day moving average is $584.42 and its 200 day moving average is $533.63. UnitedHealth Group Incorporated has a 12 month low of $436.38 and a 12 month high of $608.63.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $7.00 by $0.15. The business had revenue of $100.82 billion for the quarter, compared to analysts’ expectations of $99.14 billion. UnitedHealth Group had a return on equity of 26.55% and a net margin of 3.66%. The firm’s quarterly revenue was up 9.2% on a year-over-year basis. During the same quarter in the prior year, the firm posted $6.56 EPS. Sell-side analysts expect that UnitedHealth Group Incorporated will post 27.68 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Tuesday, September 24th. Stockholders of record on Monday, September 16th were given a dividend of $2.10 per share. The ex-dividend date of this dividend was Monday, September 16th. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.47%. UnitedHealth Group’s dividend payout ratio (DPR) is presently 55.70%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.